Adero Partners’s Elevance Health ELV Stock Holding History

Adero Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-892	Closed	-$464K	–	265
2024 Q3	$464K	Sell	892 -40	-4%	-$21.4K	0.03%	130
2024 Q2	$505K	Buy	932 +310	+50%	+$164K	0.04%	117
2024 Q1	$323K	Buy	622 +28	+5%	+$13.9K	0.02%	153
2023 Q4	$280K	Buy	594 +87	+17%	+$40.2K	0.02%	151
2023 Q3	$221K	Buy	+507	New	+$230K	0.02%	165
2022 Q2	–	Sell	-408	Closed	-$201K	–	156
2022 Q1	$201K	Buy	+408	New	+$186K	0.03%	153

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Adero Partners's ELV Position: Q4 2024 in Review

Adero Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 892 shares — an estimated $464K sold.

Adero Partners first reported a position in ELV in Q1 2022 and held it in 6 quarters. The position peaked at $505K in Q2 2024. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Adero Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Adero Partners sold 892 Elevance Health shares in Q4 2024, an estimated $464K.
Adero Partners first reported a position in Elevance Health in Q1 2022 and held it in 6 quarters.
Adero Partners's Elevance Health position peaked at $505K in Q2 2024.
1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Adero Partners's 13F filing for Q4 2024, filed 27 Jan 2025.